Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-12-019611
Filing Date
2012-09-14
Accepted
2012-09-14 10:41:07
Documents
1
Period of Report
2012-09-11

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 4250
  Complete submission text file 0001225208-12-019611.txt   5672
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 223A MAIN ST BOXFORD MA 021921
Business Address
PYKETT MARK JEROME (Reporting) CIK: 0001278271 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 121091603